Laparoscopic retroperitoneal lymph node dissection for testicular cancer

Area of Science:

• Urology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Laparoscopic retroperitoneal lymph node dissection (L-RPLND) has been available for over two decades as a less invasive alternative to open surgery.
• It is utilized in the treatment of testicular cancer.

Purpose of the Study:

• To review the indications, surgical techniques, and outcomes of L-RPLND in patients with testicular cancer.
• To compare L-RPLND with open retroperitoneal lymph node dissection (RPLND).

Main Methods:

• A systematic literature search was conducted using MEDLINE.
• Keywords included 'laparoscopy', 'retroperitoneal lymph node dissection', 'RPLND', and 'testicular neoplasms'.
• Articles were selected based on relevance, study design, and content, prioritizing recent data.

Main Results:

• 14 studies comprising over 1300 patients (515 L-RPLND, 788 open RPLND) were analyzed.
• L-RPLND had longer operative times but shorter hospital stays and lower complication rates (15.6% vs. 33%).
• Oncological outcomes, including relapse and cure rates, were similar between L-RPLND and open RPLND.

Conclusions:

• No randomized controlled trials directly compare L-RPLND and open RPLND.
• Review of case and comparative series indicates similar perioperative and oncological outcomes.
• L-RPLND patients experience shorter hospital stays, quicker return to normal activities, and improved cosmetic results.